From post

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

, , , , , , , , , и . Clin. Vaccine Immunol., 17 (1): 154--159 (января 2010)
DOI: 10.1128/CVI.00384-09

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

Immunogenicity of 2 Investigational Serogroup B Meningococcal Vaccines in the First Year of Life, , , , , , , , , и 2 other автор(ы). The Pediatric Infectious Disease Journal, (2010)Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era, , , , , , и . Clinical and Vaccine Immunology: CVI, 15 (11): 1694--8 (ноября 2008)PMID: 18827191.Prevention of meningococcal serogroup C disease by NeisVac-C, и . Expert Review of Vaccines, 8 (3): 265--279 (марта 2009)PMID: 19249967.Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine, , , , , , , , , и . Clin. Vaccine Immunol., 17 (1): 154--159 (января 2010)Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy, , , , , , , , , и 3 other автор(ы). Clinical Infectious Diseases, 51 (10): 1127--1137 (ноября 2010)Immunogenicity of a Reduced Schedule of Meningococcal Group C Conjugate Vaccine Given Concomitantly with the Prevenar and Pediacel Vaccines in Healthy Infants in the United Kingdom, , , , , , , , , и . Clin. Vaccine Immunol., 16 (2): 194--199 (февраля 2009)A Multi-country Evaluation of Neisseria meningitidis Serogroup B Factor H-Binding Proteins and Implications for Vaccine Coverage in Different Age Groups, , , , , , , , , и 12 other автор(ы). The Pediatric infectious disease journal, 32 (10): 1096--1101 (октября 2013)PMID: 23694830.Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines, , , , , , , , , и 24 other автор(ы). Clinical and vaccine immunology: CVI, 19 (10): 1609--1617 (октября 2012)PMID: 22875603.Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, , , , , , , , , и 26 other автор(ы). The Lancet infectious diseases, 13 (5): 416--425 (мая 2013)PMID: 23414709.Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine, , , , , и . Journal of Occupational Medicine and Toxicology, 8 (1): 4 (марта 2013)